GreenLight Biosciences Holdings reported earnings results for the third quarter and nine months ended September 30, 2022. For the third quarter, the company reported revenue was USD 1.73 million compared to USD 0.362 million a year ago. Net loss was USD 38.16 million compared to USD 29.18 million a year ago. Basic loss per share from continuing operations was USD 0.27 compared to USD 0.3 a year ago.
For the nine months, revenue was USD 3.76 million compared to USD 1.18 million a year ago. Net loss was USD 128.29 million compared to USD 77.64 million a year ago. Basic loss per share from continuing operations was USD 1.02 compared to USD 0.81 a year ago.